StockNow
Calendar
Log in
U.S. Markets

Biogen Inc. (BIIB) Q3 2026 (USD): Adj. EPS 2.62 (exp. 1.98), Revenue 2.8bln (exp. 2.63bln). Raises lower end of FY26 diluted EPS guidance to USD 12.20-13.00 (exp. 12.23, prev. 12.00-13.00)

ORIGINAL · NewsquawkBiogen Inc. (BIIB) Q3 2026 (USD): Adj. EPS 2.62 (exp. 1.98), Revenue 2.8bln (exp. 2.63bln). Raises lower end of FY26 diluted EPS guidance to USD 12.20-13.00 (exp. 12.23, prev. 12.00-13.00)
StockNow breaking-news AI analysis

Biogen reported Q3 2026 adjusted EPS and revenue above expectations and raised the lower end of its FY26 diluted EPS guidance.

1 stocks
BIIBBiogen Inc. Common Stock$252.50Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

Ukrainian President Zelensky says Ukraine will not attack Russian ships carrying diesel for the US

Politics

Reports of a Yemeni attack targeting Saudi forces in Aden, Sabereen reports

U.S. Markets

Phillips 66 (PSX) Q3 2026 (USD): Adj. EPS 14.08 (exp. 11.73)

PSX